Drawing for INSPECTR

USPTO serial 97844741

INSPECTR

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
DONEGAN, DANIEL P
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with INSPECTR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Diagnostic preparations for scientific or research use; Diagnostic preparations for clinical or medical laboratory use; Reagents, namely, reagents for medical research testing or for scientific research use; Molecular diagnostic reagents for scientific or research use in connection with genetic materials; Diagnostic kits comprised of medical research and scientific research reagents and assays for testing bodily fluids for use in detection of nucleic acidsACTIVE—
005Diagnostic reagents for medical or veterinary use; Diagnostic biomarker reagents for medical or veterinary purposes; Reagents, namely, reagents for medical or veterinary diagnostic testing use; Molecular diagnostic reagents for medical or veterinary diagnostic use in connection with genetic materials; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in detection of nucleic acidsACTIVE—
044Medical diagnostic testing, monitoring and reporting services; veterinary diagnostic testing, monitoring and reporting services; biomedical molecular diagnostic testing, monitoring and reporting services to aid in the diagnosis and resolution of infectious diseases, genetic disorders, and cancersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Oct 21, 2024MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 21, 2024ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 19, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 23, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 23, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 3, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 14, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 13, 2023DOCKASSIGNED TO EXAMINER—
Dec 6, 2023WOAGWITHDRAWAL OF ATTORNEY GRANTED—
Dec 6, 2023WOARTEAS WITHDRAWAL OF ATTORNEY RECEIVED—
Apr 10, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 21, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance